Literature DB >> 21785471

T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia.

N Tarek, N A Kernan, S E Prockop, A Scaradavou, T N Small, R J O'Reilly, F Boulad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21785471     DOI： 10.1038/bmt.2011.142

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

Review 1.  Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders.

Authors:  Shalini Shenoy; Jaap J Boelens
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

2.  Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.

Authors:  Maria Cancio; Kyle Hebert; Soyoung Kim; Mahmoud Aljurf; Timothy Olson; Eric Anderson; Lauri Burroughs; Anant Vatsayan; Kasiani Myers; Hasan Hashem; Rabi Hanna; Biljana Horn; Tim Prestidge; Jaap-Jan Boelens; Farid Boulad; Mary Eapen
Journal:  Transplant Cell Ther       Date:  2021-10-17

3.  Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors.

Authors:  Alberto Mussetti; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Rachel Lehrman; Julianne M Ruggiero; Kevin Curran; Rachel Kobos; Richard O'Reilly; Farid Boulad
Journal:  Pediatr Hematol Oncol       Date:  2016-10-07       Impact factor: 1.969

4.  Non-myeloablative conditioning is sufficient to achieve complete donor myeloid chimerism following matched sibling donor bone marrow transplant for myeloproliferative leukemia virus oncogene (MPL) mutation-driven congenital amegakaryocytic thrombocytopenia: Case report.

Authors:  Joseph Hai Oved; Yash B Shah; Kimberly Venella; Michele E Paessler; Timothy S Olson
Journal:  Front Pediatr       Date:  2022-07-28       Impact factor: 3.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.